THE National Development Co. (NDC), a government investment agency, has poured in P70 million to Manila HealthTek Inc. (MTek), a Filipino research and development company that made the country's own reverse transcription-polymerase chain reaction swab testing kit during the pandemic.
NDC General Manager Anton Mauricio on August 15 formally turned over to MTek Executive Vice President Marlo Destura the P70-million, which represents NDC's acquisition of MTek equity.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.